The Howard Hughes Medical Institute has named Fred Hutch Cancer Center postdoctoral researcher Grant King, PhD, a Hanna H.

Fred Hutch news release clinical trial shows fecal microbiota transplantation helped with gut microbiome recovery in patients after stem cell transplantation ...

A new study from a postbaccalaureate researcher in Mark Roth’s lab at Fred Hutch Cancer Center, Cameron Suraci, shows that ...

The Vaccine and Infectious Disease Division (VIDD) is a recognized leader in translational and “bench-to-bedside” science. VIDD integrates the expertise and creativity of scientists in basic, ...

Dr. Lauren C. Shih is a hematologist and oncologist, a clinician-researcher and a health services researcher who focuses on improving care and outcomes and reducing disparities for patients with head ...

As a program within the Biostatistics Program in the Public Health Sciences Division of Fred Hutchinson Cancer Center, COMPASS has been directing multi-center studies in public health research for ...

Many cancer drugs work by inhibiting the activity of proteins — the molecules that do most of the work in the cell. But some misbehaving proteins that turn normal cells cancerous are difficult to ...

Our research includes work conducted by our Global Oncology program in sub-Saharan Africa and China as well as scores of other studies that span the globe from North and South America to Europe and ...

The Biostatistics, Bioinformatics and Epidemiology Program (BBE) supplies the statistical and mathematical modeling expertise needed within Fred Hutch’s Vaccine and Infectious Disease Division to ...

After an allogeneic stem cell transplant, a recipient’s body faces a daunting task: rebuilding the person’s blood-forming and immune systems from the ground up from a relatively small number of “seed” ...

The Value in Cancer Care Summit brings together patients, providers, clinic administrators and staff, health system representatives, nonprofit leaders, payers, researchers, academics, and industry ...